An antibody is only as useful as the interaction it forms with its target, and understanding that interaction is essential at every stage — from screening hybridomas or clones, to comparing candidate antibodies, to explaining why one binds a pathogen and another does not. Antibody characterization measures how much antibody is present, what class it belongs to, and, most importantly, where on the target it binds. Together these measurements show whether an antibody is not merely present, but fit for its intended use.

Titer and isotype determination establishes the amount and class of antibody in a sample, which is central to evaluating immune responses, monitoring production, and confirming that a chosen clone behaves as expected. Epitope mapping goes further, identifying the specific region of the antigen that the antibody recognizes — information that determines whether two antibodies can be used together, whether they will compete with a natural ligand, and whether a change in the target will affect binding.

Much of this work is outsourced because it relies on specialized assay formats and on the ability to read binding data against a structured view of the target. Working with a dedicated team keeps titer, isotype, and epitope measurements consistent across a panel of antibodies, so candidate comparisons rest on data that were gathered the same way.

What the Service Covers

• Antibody titer determination – quantifying the amount of antigen-specific antibody in a sample, whether serum, culture supernatant, ascites, or a purified preparation, and tracking how that amount changes over time or between samples.
• Isotype and subtype determination – identifying the class of the antibody, which indicates the nature and stage of an immune response and carries implications for function and downstream use.
• Epitope identification and mapping – determining which region of the antigen the antibody recognizes, using peptide-based, mutagenesis-based, or competition approaches, and characterizing binding to peptide antigens directly.

What Each Measurement Tells You

The measurements build on each other: quantity and class place an antibody in context, while the epitope explains its behavior.

Workflow

• Define the panel and the question – agree the antibodies and antigens involved, and what the characterization needs to support.
• Prepare antigen and samples – supply or produce the antigen and bring the antibody samples into a consistent format.
• Measure titer and isotype – quantify the specific antibody and determine its class across the panel.
• Map the epitopes – identify the recognized region and establish whether antibodies compete or can be paired.
• Report – deliver the results as a comparative panel summary with an interpretation of what the data mean.

Applications

• Antibody discovery – screen and rank clones or hybridomas by how much specific antibody they produce and where it binds.
• Immune response monitoring – follow titer and isotype in serology or vaccination studies to describe the response over time.
• Antibody pairing – select non-competing antibodies for sandwich assays and multi-antibody panels by mapping their epitopes.
• Comparability studies – compare batches or different sources of an antibody by titer, isotype, and epitope behavior.
• Target-variant assessment – judge whether mutations or sequence variants in the antigen will affect antibody recognition.
• Peptide-antigen work – characterize antibodies raised against or directed at peptide antigens.

Why Work With Us

Antibody comparisons are only meaningful when every antibody in a panel is measured the same way. We run titer, isotype, and epitope analysis under consistent conditions, interpret binding results against a structured view of the target, and report the panel as a comparable set rather than a stack of unrelated numbers. Where an epitope cannot be resolved to a single site, we describe it as a region and say what the data support, so the result is useful for selection and pairing decisions without overstating its precision.